Percheron Therapeutics (AU:PER) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Percheron Therapeutics has reported a significant change in its substantial shareholding, as Platinum Investment Management disclosed an increase in its stake to 10 million ordinary shares, representing 9.5796% of the company. This development could signal increased confidence in Percheron’s growth prospects, attracting the attention of investors keen on biotechnology stocks.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.